(Q51565712)

7 April 2018

title

Effects of fibric acid derivatives and metformin on postprandial lipemia. (English)

1 reference

7 April 2018

1 reference

1 reference

Weintraub MS

1

1 reference

7 April 2018

Charach G

series ordinal

2

1 reference

7 April 2018

Grosskopf I

series ordinal

3

1 reference

7 April 2018

publication date

1 December 1998

1 reference

7 April 2018

published in

Atherosclerosis

1 reference

7 April 2018

volume

141 Suppl 1

1 reference

7 April 2018

page(s)

S71-5

1 reference

7 April 2018

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

The relationship of abnormal circulating insulin levels to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Atherogenesis: a postprandial phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Plasma insulin and lipoprotein concentrations: an atherogenic association?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-β disease (type III hyperlipoproteinemia)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Arterial influx of esterified cholesterol from two plasma lipoprotein fractions and its hydrolysis in vivo in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Comparison of cholesteryl ester transfer from chylomicrons and other plasma lipoproteins to aortic intima media of cholesterol-fed rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Chylomicron clearance in normal and hyperlipidemic man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Quantitative study of insulin secretion and clearance in normal and obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900221-4

10.1016/S0021-9150(98)00221-4

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

9888646

1 reference

7 April 2018